Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.

Krebs S, Salem AE, Nguyen NC, Sheth RA, Karam JA, Daw NC, Tang C, Tannir NM, Msaouel P, Surasi DS

Open source

DOI
10.2967/jnumed.126.272258
Published
2026 Sep 2
Container
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2967/jnumed.126.272258,
  title = {Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.},
  author = {Krebs S and Salem AE and Nguyen NC and Sheth RA and Karam JA and Daw NC and Tang C and Tannir NM and Msaouel P and Surasi DS},
  year = {2026},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  doi = {10.2967/jnumed.126.272258},
  url = {https://doi.org/10.2967/jnumed.126.272258}
}

RIS

TY  - JOUR
TI  - Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.
AU  - Krebs S
AU  - Salem AE
AU  - Nguyen NC
AU  - Sheth RA
AU  - Karam JA
AU  - Daw NC
AU  - Tang C
AU  - Tannir NM
AU  - Msaouel P
AU  - Surasi DS
PY  - 2026
JO  - Journal of nuclear medicine : official publication, Society of Nuclear Medicine
DO  - 10.2967/jnumed.126.272258
UR  - https://doi.org/10.2967/jnumed.126.272258
ER  - 

APA

S, K., AE, S., NC, N., RA, S., JA, K., NC, D., C, T., NM, T., P, M., & DS, S. (2026). Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272258

Source records